RxDoctor Payments DataLook up a doctor →

Megan Coylewright

Interventional Cardiology · Calhoun, GANPI 1003961772

Payments from drug & device makers

$2,256,749in general payments, 2019–2025

Across 523 payments — averaging $4315.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.3M
  • Boston Scientific$738K
  • Medtronic$147K
  • Abbott$72K
  • Recor Medical Inc$6K
  • W. L. Gore & Associates, Inc.$1K
  • plus $1K from 12 others
$76,566in research payments, 2019–2025

Across 34 payments — averaging $2251.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$77K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,256,749 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Other interventional cardiology in Calhoun

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →